(Q38872361)

English

miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy

scientific article published on 19 May 2015

In more languages
default for all languages
No label defined

No description defined

Statements

miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit